These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Adverse Impact of Tumor Microenvironment on NK-Cell. Hu Z; Xu X; Wei H Front Immunol; 2021; 12():633361. PubMed ID: 34177887 [TBL] [Abstract][Full Text] [Related]
6. Natural killer group 2D receptor and its ligands in cancer immune escape. Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924 [TBL] [Abstract][Full Text] [Related]
7. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy. Gaggero S; Witt K; Carlsten M; Mitra S Front Immunol; 2020; 11():621225. PubMed ID: 33584718 [TBL] [Abstract][Full Text] [Related]
9. Escape of tumor cells from the NK cell cytotoxic activity. Cantoni C; Wurzer H; Thomas C; Vitale M J Leukoc Biol; 2020 Oct; 108(4):1339-1360. PubMed ID: 32930468 [TBL] [Abstract][Full Text] [Related]
10. Platelet-Mediated Protection of Cancer Cells From Immune Surveillance - Possible Implications for Cancer Immunotherapy. Schmied L; Höglund P; Meinke S Front Immunol; 2021; 12():640578. PubMed ID: 33777033 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of tumor cells escaping from immune surveillance of NK cells. Ge Z; Wu S; Zhang Z; Ding S Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):187-198. PubMed ID: 32223464 [TBL] [Abstract][Full Text] [Related]
12. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy? Ben-Shmuel A; Biber G; Barda-Saad M Front Immunol; 2020; 11():275. PubMed ID: 32153582 [TBL] [Abstract][Full Text] [Related]
14. Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors. Melaiu O; Lucarini V; Cifaldi L; Fruci D Front Immunol; 2019; 10():3038. PubMed ID: 32038612 [TBL] [Abstract][Full Text] [Related]
15. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells. Kim N; Kim HS Front Immunol; 2018; 9():2041. PubMed ID: 30250471 [TBL] [Abstract][Full Text] [Related]
16. NK Cells and Cancer Immunoediting. Guillerey C; Smyth MJ Curr Top Microbiol Immunol; 2016; 395():115-45. PubMed ID: 26025472 [TBL] [Abstract][Full Text] [Related]
17. Functional and metabolic targeting of natural killer cells to solid tumors. Wang J; Matosevic S Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy. Devillier R; Chrétien AS; Pagliardini T; Salem N; Blaise D; Olive D J Leukoc Biol; 2021 Jun; 109(6):1071-1088. PubMed ID: 32991746 [TBL] [Abstract][Full Text] [Related]
19. NK cells to cure cancer. Di Vito C; Mikulak J; Zaghi E; Pesce S; Marcenaro E; Mavilio D Semin Immunol; 2019 Feb; 41():101272. PubMed ID: 31085114 [TBL] [Abstract][Full Text] [Related]
20. Cancer extracellular vesicles as novel regulators of NK cell response. Soriani A; Vulpis E; Cuollo L; Santoni A; Zingoni A Cytokine Growth Factor Rev; 2020 Feb; 51():19-26. PubMed ID: 31837917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]